Niki BioSolutions, Inc. (NIKI) Preferred Stock Liabilities (2022 - 2025)

Niki BioSolutions (NIKI) has 4 years of Preferred Stock Liabilities data on file, last reported at $4441.0 in Q4 2025.

• Quarterly Preferred Stock Liabilities changed N/A year-over-year to $4441.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $4441.0 (changed N/A YoY) and the FY2025 annual result came in at $47000.0, up 126927.03% from the prior year.
• Preferred Stock Liabilities was little changed at $4441.0 in Q4 2025, from $4441.0 in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $22.4 million in Q4 2022 to a low of $31.0 in Q2 2023.
• A 4-year average of $3.7 million and a median of $4441.0 in 2024 frame the typical range for Preferred Stock Liabilities.
• Annual changes were most pronounced in 2023 — Preferred Stock Liabilities slumped 100.0% — and 2025, when it changed 0.0%.
• Tracing NIKI's Preferred Stock Liabilities over 4 years: stood at $22.4 million in 2022, then tumbled by 100.0% to $31.0 in 2023, then surged by 14225.81% to $4441.0 in 2024, then changed by 0.0% to $4441.0 in 2025.
• The last three Preferred Stock Liabilities figures came in at $4441.0 (Q4 2025), $4441.0 (Q2 2025), and $4441.0 (Q2 2024), per Business Quant data.